MONDAY, Nov. 10, 2025 (HealthDay News) — Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million people estimated to be living with ...

An international expert panel has developed consensus guidelines to help clinicians navigate multiple sclerosis (MS) diagnosis in atypical populations — specifically children and older adults. Here's ...

The biggest difference between ocrelizumab and the recently approved ofatumumab is that ofatumumab can be taken at home for relapsing forms of multiple sclerosis (MS), explained Patricia K. Coyle, MD.

Neurofilament light chain is a promising noninvasive biomarker for multiple sclerosis (MS), but lacks disease specificity due to other neurological causes. Apolipoprotein levels are negatively ...

Autoimmune diseases such as multiple sclerosis arise when the immune system turns against the body itself. Yet for most of ...

An estimated 2.3 million individuals are living with multiple sclerosis (MS) worldwide. Approximately half of all individuals with MS experience changes in cognition such as impaired concentration, ...

Modern scientific understanding has considered multiple sclerosis (MS) to be a disease controlled by the T cell, a type of white blood cell. Research has shown that in MS, T cells inappropriately ...

Levels of two types of bacteria in your gut could help improve the diagnosis and treatment of multiple sclerosis. When you purchase through links on our site, we may earn an affiliate commission. Here ...